NCT06261554View on ClinicalTrials.gov

Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients

NARecruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 14, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2027

Conditions
Food Allergy
Interventions
DIETARY_SUPPLEMENT

Dietary Supplement: Low dose OIT

Following the building-up phase (up to 14 months), patients will receive a daily low dose of sesame paste (300 mg sesame protein) mixed with well-tolerated fruit mousse or bread for 3 months (12 +/- 3 weeks).

Trial Locations (1)

02-091

RECRUITING

Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER